Authentica Global
Markets S&P 500 7,543.64 ▲ 0.81% Nasdaq 26,206.89 ▲ 1.30% Dow Jones 52,487.41 ▲ 0.27% US 10 Yr 4.54 ▼ 0.66% Crude Oil 71.87 ▼ 0.29% Gold 4,131.40 ▼ 0.23% Bitcoin 63,175 ▲ 1.51% FTSE 100 10,472.45 ▼ 0.16% EUR/USD 1.1436 ▲ 0.02% Nikkei 225 67,743.85 ▲ 1.38%
Topic archive

Wegovy

Reporting, analysis and commentary on Wegovy from Authentica Global, drawn together from across our coverage.

1 article Latest update: 5 Jul 2026 1 section
Related sections Health
Related topics Medicare GLP-1 Bridge $50 copay Medicare GLP-1 drugs Zepbound weight loss Part D coverage
Tag lead
A senior patient at a pharmacy counter receiving a GLP-1 weight loss medication under Medicare coverage
Health

Millions of Seniors Can Now Get the Medicare GLP-1 Bridge $50 Copay for Weight Loss

3.8 million Medicare beneficiaries can now obtain Wegovy, Zepbound, or the new pill Foundayo for weight loss at a flat $50 monthly copay under a Bridge program that began July 1, 2026, the first obesity-drug coverage in over two decades.

5 Jul 2026 ·8 min read
Keep reading

More paths through this story

This archive gathers Authentica Global coverage of Wegovy, bringing together the reporting, analysis and commentary connected to the subject.

Related topics

Medicare GLP-1 Bridge $50 copay Medicare GLP-1 drugs Zepbound weight loss Part D coverage Federal Reserve Donald Trump AI infrastructure nonfarm payrolls

Related sections

Health

Latest nearby

Health · 5 Jul 2026 Colorado Enbrel Price Cap Blocked, Pharma Pockets the Win Health · 5 Jul 2026 US Measles Elimination Status 2026 Cracks at 2,170 Cases Health · 5 Jul 2026 Aetna, Cigna Headline ACA Marketplace Insurers Exit 2026 Health · 5 Jul 2026 Dead Skua Marks First H5N1 Bird Flu Australia Detection